s6y
Company name or ticker
Search
Biomea Fusion, Inc.
3
A2A Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
Filed
Monday, April 26, 2021
Period
Apr 15, 2021
Accession number
0000899243-21-016975
Documents
FORM 3 SUBMISSION
3
On sec.gov
Filing index
All files
Complete submission text
SGML header